Fintel on MSN1d
Scotiabank Initiates Coverage of Sarepta Therapeutics (SRPT) with Sector Perform Recommendation
Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Sarepta Therapeutics (NasdaqGS:SRPT) with a Sector ...
Zacks Investment Research on MSN2d
SLDB Stock Rallies 60% in a Month: Here's What You Should Know
Shares of Solid Biosciences SLDB have rallied 59.9% in the past month. The stock price increase was mainly due to positive ...
Sarepta initiated with a Sector Perform at Scotiabank
Scotiabank analyst Louise Chen initiated coverage of Sarepta (SRPT) with a Sector Perform rating and $105 price target The firm says that ...
A Closer Look At Sarepta Therapeutics' Earnings
NasdaqGS:SRPT Earnings and Revenue History March 7th 2025 A Closer Look At Sarepta Therapeutics' Earnings. In high finance, the key ratio used to measure how well a company conver ...
Oppenheimer Asset Management Inc. Decreases Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Oppenheimer Asset Management Inc. decreased its stake in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 8.5% during the fourth quarter, HoldingsChannel.com reports. The ...
Signs of hiring at Boston-area life sciences companies
Some of Massachusetts’ largest life sciences employers, as well as smaller biotechs, increased their headcount in 2024, ...
Sarepta Therapeutics' Long-Term Potential Intact Despite Near-Term Stock Weakness
Sarepta Therapeutics hits 52-week lows despite strong earnings and growth. Read why investors should view SRPT as a high risk ...
Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...
Sarepta files automatic mixed securities shelf
EST Sarepta (SRPT) files automatic mixed securities shelfDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...